AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment

Cardiovascular Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Hemodialysis: A Meta-Analysis

(2010) D. J. Tai et al.   Clinical Journal of the American Society of Nephrology

Candesartan effect on inflammation in hypertension

(2010) Giuseppe Derosa et al.   HYPERTENSION RESEARCH

Oxidative DNA damage in chronic renal failure patients

(2009) E. Stoyanova et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Angiotensin II Induces DNA Damage in the Kidney

(2008) U. Schmid et al.   CANCER RESEARCH

DNA double-strand breaks: A potential causative factor for mammalian aging?

(2008) Han Li et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Induction and removal of DNA damage in blood leukocytes of patients with type 2 diabetes mellitus undergoing hemodialysis

(2008) Pamela Brambilla Bagatini et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients

(2008) Nicole Schupp et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation

(2008) H. Stopper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Spontaneous DNA Repair Increases during Hemodialysis

(2008) Michal Herman et al.   NEPHRON CLINICAL PRACTICE

Angiotensin II–Mediated Oxidative DNA Damage Accelerates Cellular Senescence in Cultured Human Vascular Smooth Muscle Cells via Telomere-Dependent and Independent Pathways

(2007) Karl E. Herbert et al.   CIRCULATION RESEARCH